Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchmed China Ltd (13 HK)
Watchlist
166
Analysis
Industrials
•
Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
26 Apr 2024 20:30
Hutchmed Announces Positive Chmp Opinion For Fruquintinib In Previously Treated Metastatic Colorectal Cancer Received By Takeda
Attachment
Exchange Announcement •
22 Apr 2024 16:33
Vesting Of Awards Under The Long Term Incentive Plan
Attachment
Exchange Announcement •
17 Apr 2024 16:37
Audit Committee - Terms Of Reference
Attachment
Exchange Announcement •
08 Apr 2024 16:36
Notification Letter To Registered Holders And Reply Form: (1) Annual General Meeting ("Agm") ; And (2) Notice Of Publication Of The 2023 Annual Report, Circular, Notice Of Agm And Form Of Proxy In Relation To The Agm And 2023 Sustainability Report
Attachment
Exchange Announcement •
08 Apr 2024 16:36
Notification Letter To Non-Registered Shareholders And Reply Form: (1) Annual General Meeting ("Agm") ; And (2) Notice Of Publication Of The 2023 Annual Report, Circular, Notice Of Agm And Form Of Proxy In Relation To The Agm And 2023 Sustainability Report
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x